These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28427930)

  • 1. The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services.
    Libuy N; de Angel V; Ibáñez C; Murray RM; Mundt AP
    Schizophr Res; 2018 Apr; 194():13-17. PubMed ID: 28427930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in cannabis or cocaine-related dependence and alcohol/drug treatment in Argentina, Chile, and Uruguay.
    Mauro PM; Gutkind S; Rivera-Aguirre A; Gary D; Cerda M; Santos EC; Castillo-Carniglia A; Martins SS
    Int J Drug Policy; 2022 Oct; 108():103810. PubMed ID: 35939947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
    Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses.
    Parker MA; Sigmon SC; Villanti AC
    Addict Behav; 2019 Dec; 99():106112. PubMed ID: 31476691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Asthma and cannabis, cocaine or heroin use].
    Underner M; Peiffer G; Perriot J; Jaafari N
    Rev Mal Respir; 2020 Sep; 37(7):572-589. PubMed ID: 32653338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders.
    Vergara-Moragues E; González-Saiz F; Lozano OM; Betanzos Espinosa P; Fernández Calderón F; Bilbao-Acebos I; Pérez García M; Verdejo García A
    Psychiatry Res; 2012 Dec; 200(2-3):734-41. PubMed ID: 22910475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.
    Dixon L
    Schizophr Res; 1999 Mar; 35 Suppl():S93-100. PubMed ID: 10190230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled family study of cannabis users with and without psychosis.
    Proal AC; Fleming J; Galvez-Buccollini JA; Delisi LE
    Schizophr Res; 2014 Jan; 152(1):283-8. PubMed ID: 24309013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.
    Manrique-Garcia E; Zammit S; Dalman C; Hemmingsson T; Andreasson S; Allebeck P
    Psychol Med; 2012 Jun; 42(6):1321-8. PubMed ID: 21999906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Helle S; Ringen PA; Melle I; Larsen TK; Gjestad R; Johnsen E; Lagerberg TV; Andreassen OA; Kroken RA; Joa I; Ten Velden Hegelstad W; Løberg EM
    Schizophr Res; 2016 Jan; 170(1):217-21. PubMed ID: 26682958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between patterns of cannabis use, abuse and dependence and recent stimulant use: Evidence from two national surveys in Ireland.
    Millar SR; Mongan D; O'Dwyer C; Smyth BP; Perry IJ; Galvin B
    PLoS One; 2021; 16(8):e0255745. PubMed ID: 34370775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of illicit drug use and dependence, and their contribution to the global burden of disease.
    Degenhardt L; Hall W
    Lancet; 2012 Jan; 379(9810):55-70. PubMed ID: 22225671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.